The FT News Briefing is supported by Equinole, the UK's energy partner.

Learn more at equinole.co.uk

Good morning from the Financial Times. Today is Tuesday, April 18th, and this is your FT News Briefing.

Apple rolled out a big new product yesterday, and it wasn't an iPhone. A biotech group with

links to a blacklisted Chinese company plans to expand in the US, and fighting in Sudan continued

for a third day yesterday. The immediate danger is that this could spiral out of control and become

something like a civil war. The FT's Africa Editor, David Pilling, will tell us who's behind the

violent power struggle. I'm Sonya Hudson in Fromark, Filipino, and here's the news you need to start your day.

iPhone Maker Apple Yesterday rolled out a savings account, together with investment bank Goldman Sachs.

It offers US Savers 4.15% interest. That's more than 10 times the average US savings rate.

So it's a big threat to traditional banks, which have been struggling with deposit flight.

Customers have been yanking their money and putting it into money market funds or treasury bills

that pay better returns. Yesterday, three large US banks, Charles Schwab, State Street, and MNT,

reported a combined $60 billion in deposit outflows in the first quarter of this year.

A Chinese company that makes gene sequencing machines plans to expand in the US.

But analysts are concerned because this company, it's called MGI Tech, used to be a subsidiary

of a Chinese biotech group called BGI. And BGI has several companies on the US government's

blacklist. Here's the FT's US pharmaceutical correspondent, Jamie Smith.

So MGI have told us that it is a completely different company from BGI.

They've also said that their machines, which they're selling in the US, will never

send the data from Americans back to China. They say the laboratories and the research institutions

that they're working with are able to take the machines off the internet and be run completely

...